definiens: means all consideration in any form received by Biotie or any of its Affiliates from a Third Party licensee, sub -licensee or other third party for the grant of, or agreement to, a license, sublicense, sale, assignment, conveyance or other rights to develop, commercialize or otherwise exploi t SYN -115, SYN -115 Product, Licensed Technology or Termination Product Data and Regulatory Documentation relating thereto, including any upfront fees, milestone payments ( including development, regulatory, marketing and sales -based milestone payments ), lic ense maintenance fees, and royalties received by Biotie or its Affiliate from Third Parties with respect to sales of SYN -115 Product ; but excluding : ( a ) any consideration by way of funding or reimbursement for Biotie ’s or its Affiliate ’s internal costs ( ca lculated on a fully -burdened basis ) and Third Party expenses for services performed by Biotie or its Affiliate, including FTE funding at a reasonable rate and out -of - pocket costs of materials, equipment and Third Party services, provided that such internal costs and Third Party expenses are supported by reasonable documentation ; ( b ) payments for the provision of goods by Biotie or its Affiliate to compensate Biotie or its Affiliate for the fair market value of such goods ; and ( c ) payments and reimbursements of patent costs actually incurred by Biotie or its Affiliate with respect to Patents Controlled by Biotie or any of its Affiliates that claim or cover SYN -115 or SYN -115 Product